Related Experiment Video

Updated: May 24, 2026

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer
07:59

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

Vaccines in non-small cell lung cancer: rationale, combination strategies and update on clinical trials

Tommaso De Pas1, Monica Giovannini, Maria Rescigno

  • 1Medical Oncology Unit of Respiratory Tract and Sarcomas, New Drugs Development Division, European Institute of Oncology, Milan, Italy. Tommaso.depas@ieo.it

Critical Reviews in Oncology/Hematology
|February 28, 2012
PubMed

Insights

Novel cancer vaccines targeting tumor antigens show promise for non-small cell lung cancer (NSCLC). Research explores their use in both adjuvant and advanced settings, often in combination with other therapies.

Area of Science:

  • Oncology
  • Immunotherapy
  • Vaccine Development

Background:

  • Non-small cell lung cancer (NSCLC) is a leading cause of cancer mortality globally.
  • Current therapies offer limited improvement in overall prognosis for NSCLC patients.

Purpose of the Study:

  • To review key aspects of active immunotherapy and combination therapies for NSCLC.
  • To provide an update on promising vaccine developments in NSCLC treatment.

Main Methods:

  • Review of identified tumor antigens and developed specific tumor vaccines.
  • Analysis of ongoing clinical trials for NSCLC vaccines.
  • Evaluation of vaccine efficacy in both adjuvant and advanced disease settings.

Main Results:

  • Several tumor antigens have been identified for NSCLC vaccine development.
  • Anti-MUC-1 (belagenpumatucel) and anti-TGF-β(2) (BPL-25) vaccines are in Phase III trials for advanced NSCLC.
  • MAGE-A3 and PRAME vaccines are prominent in the adjuvant setting for NSCLC.

Conclusions:

  • Vaccine therapy, particularly in combination, presents a promising treatment option for NSCLC.
  • Further research and clinical trials are essential to optimize vaccine strategies for improved NSCLC patient outcomes.

More Related Videos

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...